Atrial natriuretic peptide and three-dimensional echocardiography after transcatheter closure of atrial septal defect

<p>Abstract</p> <p>Background</p> <p>Atrial septal defect (ASD) accounts for 10% of all congenital heart lesions and represent the third most congenital cardiac defect seen in adults. Atrial natriuretic peptide (ANP) is an important regulator of the sodium and volume ho...

Full description

Bibliographic Details
Main Authors: Liu Biao, Zhang Xiaoli, Huang Yaoyao, Ma Genshan, Ding Jingdong, Lu Fengxiang
Format: Article
Language:English
Published: BMC 2008-07-01
Series:Cardiovascular Ultrasound
Online Access:http://www.cardiovascularultrasound.com/content/6/1/35
id doaj-7045dbfa5c5d460a8cecb227dd70f7f3
record_format Article
spelling doaj-7045dbfa5c5d460a8cecb227dd70f7f32020-11-24T21:11:25ZengBMCCardiovascular Ultrasound1476-71202008-07-01613510.1186/1476-7120-6-35Atrial natriuretic peptide and three-dimensional echocardiography after transcatheter closure of atrial septal defectLiu BiaoZhang XiaoliHuang YaoyaoMa GenshanDing JingdongLu Fengxiang<p>Abstract</p> <p>Background</p> <p>Atrial septal defect (ASD) accounts for 10% of all congenital heart lesions and represent the third most congenital cardiac defect seen in adults. Atrial natriuretic peptide (ANP) is an important regulator of the sodium and volume homeostasis. This study was designed to investigate the changes in plasma ANP concentrations and three-dimensional echocardiography (3DE) measurements of cardiac volume in patients with ASD during transcatheter closure of defect.</p> <p>Methods</p> <p>Plasma ANP concentrations and transthoracic 3DE measurements of right ventricular volume were performed in 46 patients with ASD before closure, and at 3 days after closure. 22 healthy subjects matched for age, sex served as control subjects.</p> <p>Results</p> <p>The 46 patients (20 men, 26 women; mean age 26.32 ± 13.28, range 6 to 63 years) were diagnosed to secundum ASD (the stretched diameters of ASD were from 9~36(25.34 ± 7.80 mm), and had been successfully placed Amplatzer septal occluder (the sizes of occluder were from 11 to 40 mm). The results showed that compared with control subjects, plasma ANP concentrations were elevated in patients with ASD. Plasma ANP concentrations positively correlated significantly with pulmonary artery pressure (PAP) (r = 0.74, <it>p </it>< 0.05) and 3DE measurements of cardiac volumes (right ventricular end-diastolic (r = 0.50, <it>p </it>< 0.05) and end-systolic volume (r = 0.50, <it>p </it>< 0.05) and negatively correlated with RVEF (r = -0.38, <it>p </it>< 0.05). Transthoracic 3DE measurements of right ventricular volume and plasma ANP concentrations decreased significantly at 3 days after closure (<it>p </it>< 0.05) compared with it before closure.</p> <p>Conclusion</p> <p>Plasma ANP concentrations were markedly elevated in patients with pulmonary arterial hypertension and right ventricular volume overload and decreased significantly after closure of ASD. This study suggested that ANP may help to identify patients with ASD complicated by pulmonary arterial hypertension and right ventricular volume overload that demanded early intervention and may become effective marker for evaluating changes in cardiac load after transcatheter ASD closure.</p> http://www.cardiovascularultrasound.com/content/6/1/35
collection DOAJ
language English
format Article
sources DOAJ
author Liu Biao
Zhang Xiaoli
Huang Yaoyao
Ma Genshan
Ding Jingdong
Lu Fengxiang
spellingShingle Liu Biao
Zhang Xiaoli
Huang Yaoyao
Ma Genshan
Ding Jingdong
Lu Fengxiang
Atrial natriuretic peptide and three-dimensional echocardiography after transcatheter closure of atrial septal defect
Cardiovascular Ultrasound
author_facet Liu Biao
Zhang Xiaoli
Huang Yaoyao
Ma Genshan
Ding Jingdong
Lu Fengxiang
author_sort Liu Biao
title Atrial natriuretic peptide and three-dimensional echocardiography after transcatheter closure of atrial septal defect
title_short Atrial natriuretic peptide and three-dimensional echocardiography after transcatheter closure of atrial septal defect
title_full Atrial natriuretic peptide and three-dimensional echocardiography after transcatheter closure of atrial septal defect
title_fullStr Atrial natriuretic peptide and three-dimensional echocardiography after transcatheter closure of atrial septal defect
title_full_unstemmed Atrial natriuretic peptide and three-dimensional echocardiography after transcatheter closure of atrial septal defect
title_sort atrial natriuretic peptide and three-dimensional echocardiography after transcatheter closure of atrial septal defect
publisher BMC
series Cardiovascular Ultrasound
issn 1476-7120
publishDate 2008-07-01
description <p>Abstract</p> <p>Background</p> <p>Atrial septal defect (ASD) accounts for 10% of all congenital heart lesions and represent the third most congenital cardiac defect seen in adults. Atrial natriuretic peptide (ANP) is an important regulator of the sodium and volume homeostasis. This study was designed to investigate the changes in plasma ANP concentrations and three-dimensional echocardiography (3DE) measurements of cardiac volume in patients with ASD during transcatheter closure of defect.</p> <p>Methods</p> <p>Plasma ANP concentrations and transthoracic 3DE measurements of right ventricular volume were performed in 46 patients with ASD before closure, and at 3 days after closure. 22 healthy subjects matched for age, sex served as control subjects.</p> <p>Results</p> <p>The 46 patients (20 men, 26 women; mean age 26.32 ± 13.28, range 6 to 63 years) were diagnosed to secundum ASD (the stretched diameters of ASD were from 9~36(25.34 ± 7.80 mm), and had been successfully placed Amplatzer septal occluder (the sizes of occluder were from 11 to 40 mm). The results showed that compared with control subjects, plasma ANP concentrations were elevated in patients with ASD. Plasma ANP concentrations positively correlated significantly with pulmonary artery pressure (PAP) (r = 0.74, <it>p </it>< 0.05) and 3DE measurements of cardiac volumes (right ventricular end-diastolic (r = 0.50, <it>p </it>< 0.05) and end-systolic volume (r = 0.50, <it>p </it>< 0.05) and negatively correlated with RVEF (r = -0.38, <it>p </it>< 0.05). Transthoracic 3DE measurements of right ventricular volume and plasma ANP concentrations decreased significantly at 3 days after closure (<it>p </it>< 0.05) compared with it before closure.</p> <p>Conclusion</p> <p>Plasma ANP concentrations were markedly elevated in patients with pulmonary arterial hypertension and right ventricular volume overload and decreased significantly after closure of ASD. This study suggested that ANP may help to identify patients with ASD complicated by pulmonary arterial hypertension and right ventricular volume overload that demanded early intervention and may become effective marker for evaluating changes in cardiac load after transcatheter ASD closure.</p>
url http://www.cardiovascularultrasound.com/content/6/1/35
work_keys_str_mv AT liubiao atrialnatriureticpeptideandthreedimensionalechocardiographyaftertranscatheterclosureofatrialseptaldefect
AT zhangxiaoli atrialnatriureticpeptideandthreedimensionalechocardiographyaftertranscatheterclosureofatrialseptaldefect
AT huangyaoyao atrialnatriureticpeptideandthreedimensionalechocardiographyaftertranscatheterclosureofatrialseptaldefect
AT magenshan atrialnatriureticpeptideandthreedimensionalechocardiographyaftertranscatheterclosureofatrialseptaldefect
AT dingjingdong atrialnatriureticpeptideandthreedimensionalechocardiographyaftertranscatheterclosureofatrialseptaldefect
AT lufengxiang atrialnatriureticpeptideandthreedimensionalechocardiographyaftertranscatheterclosureofatrialseptaldefect
_version_ 1716753511844151296